Here are relevant reports on : clinical-trials-recruitment-market
-
Radioimmunoassay Market by Type (Reagents & Kits, Analyzers), End User (Hospital, Pharmaceutical Industry, Academics, Clinical Diagnostic Labs), Application (Research, Clinical Diagnostics), and Geography - Global Forecast to 2020
Radioimmunoassay (RIA) is an in-vitro assay technique that is used to measure the concentration of antigens in blood. RIA encompasses the separation of protein from a mixture by using the specificity of antibody- antigen binding and their quantitation by using radioactivity. The global radioimmunoassay (RIA) market was valued at $345.2 Million in 2014 and is expected to reach $428.4 Million in 2020 at a CAGR of 3.5% from 2015-2020.
- Published: October 2015
- Price: $ 4950
- TOC Available:
-
AI in Clinical Care Market - Global Forecast 2024 to 2030
Intel Corporation (US), Siemens Healthcare GmbH (Germany), NVIDIA Corporation (US), Medtronic (Ireland), Amazon Web Services, Inc. (US), GE Healthcare (US), Metadvice Ltd. (UK), PathAI (US), Babylon Health (UK), AiCure (US), and Arterys (US) are few key players in the AI in clinical care market globally.
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
Clinical Trial Packaging Market - Global Forecast to 2024
This study will involve the extensive use of both primary and secondary sources. The research process will involve the study of various factors affecting the industry, to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
Clinical Information systems (CIS) Market (2011-2016)
Clinical information systems include software solutions that enable efficient clinical workflow. Clinical systems include EMR, computerized physician order entry, laboratory information systems, pharmacy information systems, radiology information systems, and PACS. The clinical information systems market in developed countries is growing with higher CAGR, however emerging markets are currently very nascent. Presently, clinical information systems dominate the HIS market due to their high price and rising adoption. Budgetary constraints due to low awareness levels are however restraining market growth. The global clinical information systems market is expected to grow from $1.2 billion in 2009 to $2.8 billion in 2015, at an estimated CAGR of 14.8% from 2010 to 2015.
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
Non Clinical Information Systems Market (2011-2016)
Non-clinical healthcare systems (NCHS) facilitate revenue cycle management and also offer automatic patient billing, cost accounting, payroll, and claims management. These functions gain high significance in light of the reported fact that improper revenue cycle management in hospitals causes a 3% to 5% loss of net revenue. For a 250-bed hospital, this figure means an annual loss of $3.5 million to $7.5 million. Improved r e lat ion with payors and patients are improved revenue cycle management are driving this market. The administrative/non-clinical systems market revenue was $12.5 billion globally in 2010. The Non Clinical Information Systems Market is estimated to reach $20.9 billion in 2015 growing at a CAGR of 10.8%.
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
Clinical Research Management Systems (CRMS) Market: Trends, Opportunities, Challenges & Global Forecasts (2011-2016)
Clinical Research Management System (CRMS) is a computer-based software system used to manage large amount of data related to clinical research planning, preparation, performance, and reporting. CRMS deals with the management of pharmacovigilance tasks, clinical trial management (CTMS), and regulatory filings management. It also helps to simplify the regulatory assessment and reporting process, thereby shortening the time taken to develop and market a new drug. CRMS is offered into three different delivery modes such as on-demand CRMS, (Saas) web-based CRMS, and cloud computing-based CRMS. Clinical Research Management System (CRMS) market is divided into three categories based on end-users such as provider CRMS market, pharmaceutical CRMS market, and Clinical Research Organizations (CRO) CRMS market.
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
Clinical Analytics Market by Offering (Raw Data, Platform), Source (EHR, Trials, Claims, RWE), Use Case (CDSS, RPM, PHM, R&D, Pharmacovigilance, Precision Medicine, Regulatory), End User (Hospital, Payer, Pharma, Medtech), Region - Global Forecast to 2030
The global clinical analytics market, valued at US$27.65 billion in 2024, stood at US$33.09 billion in 2025 and is projected to advance at a resilient CAGR of 19.7% from 2024 to 2030, culminating in a forecasted valuation of US$81.32 billion by the end of the period.
- Published: October 2025
- Price: $ 4950
- TOC Available:
-
AI in Life Science Market by Offering (End-to-End, Niche/Point, AI Tech), Application (Drug Discovery, Clinical Trials, Quality Assurance, Regulatory), Tool (Machine Learning, NLP, Computer Vision), End User (Pharma, Biotech) - Global Forecast to 2031
The global AI in life science market is projected to reach USD 69.34 billion by 2031, growing at a CAGR of 26.3% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
At-Home Blood Collection Devices Market by Product (Lancets, DBS Kits), Sample Type (Liquid, Dried), Collection Method (Push-button, Laser), Device Type (Self, Professional), Application (Diagnostics, Screening, Clinical Trials) - Global Forecast to 2029
The global At-home blood collection devices market, valued at US$89.4 million in 2023, stood at US$93.5 million in 2024 and is projected to advance at a resilient CAGR of 7.6% from 2024 to 2029, culminating in a forecasted valuation of US$135.0 million by the end of the period. Several factors drive the At-home blood collection devices market. Improvement in device technology is making them less invasive, user-friendly, and less painful to the consumer; for example, bladeless or needle-free sampling.
- Published: February 2025
- Price: $ 4950
- TOC Available:
-
Europe Telehealth & Telemedicine Market by Function (Clinical Care, Teleconsult, RPM, Patient Engagement, Analytics), Application (TeleICU, Teleradiology, Telecardiology, Diabetes), Age (Adult, Pediatric), End User (Hospital, Payer) - Forecast to 2030
The Europe telehealth & telemedicine market, valued at US$22.01 billion in 2024, stood at US$24.76 billion in 2025 and is projected to advance at a resilient CAGR of 11.2% from 2025 to 2030, culminating in a forecasted valuation of US$42.04 billion by the end of the period. The growth of the Europe telehealth & telemedicine market is driven by the rising demand for remote healthcare services, increasing adoption of digital health platforms, and expanding broadband and mobile connectivity across the region.
- Published: October 2026
- Price: $ 4950
- TOC Available:
Records 21 to 30 of 50
